Matt Dellatorre

Stock Analyst at Goldman Sachs

(n/a)
# 4,838
Out of 4,944 analysts
2
Total ratings
n/a
Success rate
-10.16%
Average return

Stocks Rated by Matt Dellatorre

Viatris
Jun 6, 2025
Initiates: Neutral
Price Target: $10
Current: $10.12
Upside: -1.19%
Teva Pharmaceutical Industries
Jun 6, 2025
Initiates: Buy
Price Target: $24
Current: $16.60
Upside: +44.58%